SCHEMBL7336017

SCHEMBL7336017

Cc1ccc(-c2cccc(C(=O)N3CCN(C(c4ccccc4)c4ccccc4)CC3)c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.65
CACNA2D1 P54289 1/20 0.55
CACNA1B Q00975 1/20 0.55
CACNB1 Q02641 1/20 0.55
CACNA1C Q13936 1/20 0.55
NPSR1 Q6W5P4 4/20 0.54
MAPT P10636 2/20 0.54
TSHR P16473 2/20 0.53
USP2 O75604 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
KMT2A Q03164 3/20 0.52
SLC6A7 Q99884 1/20 0.52
MEN1 O00255 1/20 0.52
NR2E1 Q9Y466 1/20 0.52
CDK4 P11802 1/20 0.52
CCND1 P24385 1/20 0.52
ALDH1A1 P00352 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7334597 0.87 MAOB (0.61) MAOBNPSR1MAPTTSHRUSP2
SCHEMBL7329517 0.87 MEN1 (0.65) MAOBCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL4754213 0.86 MAOB (0.74) MAOBNPSR1MAPTTSHRUSP2
SCHEMBL4750972 0.85 MAOB (0.80) MAOBCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL8989066 0.83 NPSR1 (0.67) MAOBCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL19464784 0.81 SLC6A7 (0.60) MAOBMAPTTSHRUSP2KMT2A
SCHEMBL27489578 0.81 NPSR1 (0.70) MAOBCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL31350986 0.80 MAOB (1.00) MAOBCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL18397576 0.79 HPGD (0.70) KMT2AMEN1CDK4CCND1ALDH1A1
SCHEMBL16598693 0.79 MAOB (0.74) MAOBNPSR1MAPTTSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed